Tom Dilling retweeted
Adriatic is the new Pacific as durva improves PFS and OS in LS-SCLC! So proud of my mentor Prof. Suresh Senan who lead this effort - lots to unpack here on PCI, RT schedule, and choice of platinum chemo #LCSM #RadOnc @drdavidpalma @bslotman @_ShankarSiva @DrewMoghanaki
Presented at #ESMO24:
Among patients with limited-stage small-cell lung cancer, overall and progression-free survival were significantly longer with durvalumab adjuvant therapy added to standard concurrent chemoradiotherapy. Full ADRIATIC trial results: nej.md/4d0eZ5m
Tom Dilling retweeted
Insightful discussion by @gerryhanna on 4 studies exploring the intensification of both surgical and non-surgical treatments for stage 3 NSCLC in the IO era
➡️ Provocative findings, though phase 3 data will be crucial
➡️ Urgent need for predictive biomarkers
#WCLC24
Tom Dilling retweeted
TOMORROW‼️‼️👀👀
If you are a medical student interested in learning more about Moffitt Rad Onc, please sign up at the link below.
Sign up link: docs.google.com/spreadsheets…
Tom Dilling retweeted
MS4s applying to Rad Onc 👀🔥
Excited to announce our upcoming Virtual Meet & Greet session!
If you are a medical student interested in learning more about Moffitt Rad Onc, please sign up at the link below.
Sign up link: docs.google.com/spreadsheets…
Tom Dilling retweeted
Now accepting volunteers interested in serving on committees &/or subcommittees for the Society year beginning 10/1. Read this ASTROblog post feat. President-elect @SameerKeoleMD, where he encourages members to think of how one can volunteer for the field. astro.org/blog/may-2024/volu…
Tom Dilling retweeted
I research women and far-right movements in the U.S. and Europe, including why women are increasingly likely to join and how their role has changed. This speech was a masterclass. 1/
Tom Dilling retweeted
Replying to @ielnaqa
@ielnaqa, @tom_dilling and Denis Dudas recently produced a publication entitled: "Improved outcome models with denoising diffusion" Please click here to see a copy of this publication:
pubmed.ncbi.nlm.nih.gov/3832…
Tom Dilling retweeted
@ml4onco congratulates @GhasemiPayman, @tom_dilling, @SA_Rosenberg and @ielnaqa on their newest publication: "Novel Dose Criteria for Lung Cancer SBRT to Improve Local Control in Patients Treated to 50 Gy/5 Fractions Using Deep Learning Methods..." pubmed.ncbi.nlm.nih.gov/3778…
FLAURA2 just presented at #WCLC2023: Osimertinib + Cheo PFS > Osimertinib alone. (Sorry for blurry slide!)
MARS 2 study just presented at #WCLC2023. Inferior OS for pts who underwent pleurectomy/decorticati on compared to those who received systemic tx alone.
Tom Dilling retweeted
Please retweet this ad immediately. Twitter has blocked her campaign from promoting this ad due to its support for abortion rights. This is the Democrat running for Lt. Governor of North Carolina. Help her promote it for free by hitting retweet.
Had a great time hearing about interesting research at USF!
#BAI - Biomedical AI inaugural workshop today at @ml4onco @MoffittNews . We hosted @USouthFlorida faculty and heads of various Departments from several Colleges led by #RandyLarsen who were eager to learn about our department and collaborative opportunities arising.
Tom Dilling retweeted
Me in 1999: I wish I could do films every day before radiation to be sure we are doing it safely and precisely. Me in 2022: I wish the insurance co would allow me to do films every day before radiation to be sure we are doing it safely and precisely. #fixpriorauth #radonc
Tom Dilling retweeted
@ml4onco
is seeking highly motivated and collaborative individuals with expertise in artificial intelligence, machine and deep learning who are interested in applying this expertise to cancer research and translational oncology.
moffitt.org/research-science…
Great to have our residents spend time with the incomparable Charles Thomas!
Grateful for our fantastic mentorship session with Dr. Charles Thomas! @MoffittRadOnc @KOSJ12
Tom Dilling retweeted
Sarah E. Hoffe, MD, Section Head, GI Radiation Oncology, Senior Member, Cancer Center Director of Radiation Oncology Virtual Reality and Innovation discusses "the evolving role of radiation therapy for pancreatic cancer" during the #RueschSymposium. @MoffittNews @LombardiCancer
Tom Dilling retweeted
👇Appreciate @ASCOPost highlighting our RCT ⚖️ presented at #ASTRO22.
Promising role for #radonc to ⬇️ SRE, hospitalizations, pain for patients w/ asymptomatic high-risk bone mets. Important Qs remain re subset of patients that benefit.
✍️ Manuscript coming soon! @JYangMDPhD
From the @ASCOPost: Randomized Phase II Trial Shows Benefits of Prophylactic Radiation Therapy for Asymptomatic Bone Metastases @ErinGillespieMD Read more here: ow.ly/zEtr50LIcOA
Tom Dilling retweeted
The Machine Learning Department at Moffitt Cancer Center @ml4onco currently has a Postdoctoral Fellow – Natural Language Processing / Machine Learning in Healthcare position available. Please click moffitt-cancer-center-career… to view more information. #NLP #postdoc #jobopenings
Tom Dilling retweeted
No training can prepare you for discussing hospice with your patient when she is holding her 6 month baby.
Lung cancer is killing our women. – at New Haven, CT







































